CADD Pump Infusion Set Recall Issued Over Risk of Medication Delivery Failure Risk

|

Smith Medical has issued a recall for infusion sets used with CADD pumps, due to a risk that they may malfunction and under-deliver fluids or medication needed for life-sustaining therapy.

The CADD Pump Infusion Sets recall was announced by the U.S. Food and Drug Administration (FDA) on January 5, warning healthcare providers that the infusion systems may signal false alarms or supply insufficient fluid to patients if the tubing becomes blocked.

The infusion systems are designed to programmatically deliver specified amounts of chemotherapy, fluids and antibiotics to patients based on the healthcare providerโ€™s judgement. The sets are equipped with medication cartridges and tubing that connects to the infusion pump.

According to the recall announcement, a manufacturing defect may allow the green CADD Flow Stop arm to partially obstruct the tubing when delivering fluids to patients. Healthcare professionals are being warned the pump will not display an error in the dosage delivery.

Officials indicate patients could receive a lack, or under delivery, of life sustaining fluids, increasing the risk of serious injury or death.

While no reports of injuries or deaths were outlined in the recall announcement, healthcare professionals are being instructed to follow a specific series of instructions to avoid possible harm to patients.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Smith Medical also indicates there is a second problem with the CADDTM Infusion System Infusion Sets, which involves false alarms. The CADD-Legacy pumps may not detect when 50 ml and 700 ml CADD Medication Cassette Reservoirs with Flow Stop are attached to the pump, even when they are properly attached.

If the attachments are not recognized, the pump will signal a NOA alarm. The manufacturer states that to address the issue, the user must clear the alarm and resolve the cause of the NOA event before using the pump. The false alarm problems are isolated to CADD-Legacy pumps, which Smiths Medical stopped selling in December 2022.

Smith Medical issued an Urgent Medical Device Correction Letter to customers on December 12, 2022, outlining the potential risks related to both issues. The letter provided the specific list of affected products with device-specific instructions.

For additional questions or concerns regarding the recall, customers may contact Smith Medicalโ€™s Global Complaint Management at 1-(866)-216-8806 to report adverse events or product complaints, or for Technical Assistance call 1-(800)-258-5361.

Russell Maas
Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A FanDuel addiction lawsuit claims a Pennsylvania man wagered massive amounts of money after being subjected to a tailored promotional campaign designed to exploit his gambling habits.
A spinal cord stimulator lawsuit from a Kentucky man claims his Boston Scientific device was defectively designed, leaving him with permanent nerve damage and wire fragments fused into his bones.
A federal judge has called for a meeting between attorneys representing plaintiffs and defendants in Covidien mesh lawsuits following an $88 million verdict against the manufacturers.